News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Release: Major Shareholder Announcement


1/30/2014 8:57:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; January 29, 2014 – Genmab A/S (OMX: GEN) announce under reference to Section 29 of the Danish Securities Trading Act that Johnson & Johnson Development Corporation (JJDC) has informed us that as of January 29, 2014 their total shareholding in Genmab A/S after the execution of the capital increase in Genmab A/S, executed on January 29, 2014, consists of 5,400,000 shares corresponding to 9.58% of the share capital and voting rights in Genmab A/S.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES